Both in R&D — Physical & Biological Sciences
MaxCyte vs OmniAb
Over the past year MXCT returned +10.3% and OABI returned +240.6%; their daily moves had a correlation of 0.29.
MXCT +10.3% OABI +240.6%Growth of $1, one year, split-adjusted
| Metric | MXCT | OABI |
|---|---|---|
| Price | $1.71 | $5.28 |
| Market cap | $176.5M | $767.7M |
| Today | +11.04% | +6.45% |
| 1 month | +44.9% | +11.4% |
| 6 months | +109.1% | +288.2% |
| Year to date | +10.3% | +185.4% |
| 1 year | +11.0% | +232.1% |
| Revenue growth (YoY) | −14.5% | +244.2% |
| Gross margin | 77.0% | 95.5% |
| Net margin | −122.0% | −43.7% |
| P/E (TTM) | — | — |
| Price / sales | 5.7× | 20.0× |
| Net cash | $105.7M | $52.0M |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 98.1% |
| Short % of float | 2.0% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).